nach oben

Diabetologia

Erschienen in:

01.07.2008 | Article

Transcription factor expression in the developing human fetal endocrine pancreas

verfasst von: B. M. Lyttle, J. Li, M. Krishnamurthy, F. Fellows, M. B. Wheeler, C. G. Goodyer, R. Wang

Erschienen in: Diabetologia | Ausgabe 7/2008

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Morphological changes that occur during pancreatic endocrine cell differentiation have been shown in rodent systems to be dependent on sequential alterations in transcription factor expression. However, similar data for humans have been limited. The aim of the present study was to provide a connection between pancreatic morphology, transcription factor gene expression and protein localisation during human fetal development.

Methods

Human fetal pancreases were examined at early (8–12 weeks of fetal age), middle (14–16 weeks) and late (19–21 weeks) stages, using immunohistological, microarray and qRT-PCR analyses.

Results

We observed a significant decrease in pancreatic duodenal homeobox 1 (PDX-1)⁺/cytokeratin 19⁺ cells (p < 0.001), with a simultaneous increase in PDX-1⁺/insulin⁺ cells from 8 to 21 weeks (p < 0.05). Increased PDX-1/insulin co-localisation within islet clusters was noted, while no co-expression of PDX-1 with glucagon was found, suggesting that loss of PDX-1 is essential for alpha cell formation. Given that neurogenin 3 (NGN3) expression is critical for establishing the endocrine cell programme in the rodent pancreas, we examined its expression pattern and co-localisation in PDX-1⁺, insulin⁺ and glucagon⁺ cells. Co-localisation of NGN3 with PDX-1, insulin and glucagon was noted during early development, with significant decreases in middle and late stages (p < 0.001). Our microarray and co-localisation analyses of transcription factors linked to NGN3 demonstrated that ISL1 transcription factor (ISL1), neurogenic differentiation 1 (NEUROD1), NK2 related transcription factor related, locus 2 (NKX2-2) and paired box gene 6 (PAX6) were upregulated during development and present in all four endocrine cell types, while NK6 related transcription factor related, locus 1 (NKX6-1) was expressed exclusively in beta cells.

Conclusions/interpretation

This study is an important step towards identifying key molecular factors involved in development of the human fetal endocrine pancreas.

Nur mit Berechtigung zugänglich

Hao E, Tyrberg B, Itkin-Ansari P et al (2006) Beta cell differentiation from nonendocrine epithelial cells of the adult human pancreas. Nat Med 12:310–314PubMedCrossRef

Meier JJ, Bhushan A, Butler PC (2005) The potential for stem cell therapy in diabetes. Ped Res 59:65–73CrossRef

Jiang J, Au M, Eshpeter A, Korbutt G, Fisk G, Majumdar AS (2007) Generation of insulin-producing islet-like clusters from human embryonic stem cells. Stem Cells 25:1940–1953PubMedCrossRef

Stefan Y, Grasso S, Perrelet A, Orci L (1983) A quantitative immunofluorescent study of the endocrine cell populations in the developing human pancreas. Diabetes 32:293–301PubMedCrossRef

Bouwens L, Lu WG, De Krijger R (1997) Proliferation and differentiation in the human fetal endocrine pancreas. Diabetologia 40:398–404PubMedCrossRef

Piper K, Brickwood S, Turnpenny LW et al (2004) Beta cell differentiation during early human pancreas development. J Endocrinol 181:11–23PubMedCrossRef

Polak M, Bouchareb-Banaei L, Scharfmann R, Czernichow P (2000) Early pattern of differentiation in the human pancreas. Diabetes 49:225–232PubMedCrossRef

Gupta V, Garg K, Rajeha S, Choudhry R, Tuli A (2002) The histogenesis of islets in the human fetal pancreas. J Anat Soc India 51:23–26

Sander M, German MS (1997) The beta cells transcription factors and development of the pancreas. J Mol Med 75:327–340PubMedCrossRef

10.

Conklin JL (1962) Cytogenesis of the human fetal pancreas. Am J Anat 111:181–193PubMedCrossRef

11.

Kim SK, Hebrok M (2001) Intercellular signals regulating pancreas development and function. Genes Dev 15:111–127PubMedCrossRef

12.

Collombat P, Hecksher-Sorensen J, Serup P, Mansouri A (2006) Specifying pancreatic endocrine cell fates. Mech Dev 123:501–512PubMedCrossRef

13.

Chakrabarti SK, Mirmira RG (2003) Transcription factors direct the development and function of pancreatic beta cells. Trends Endocrinol Metab 14:78–84PubMedCrossRef

14.

Gradwohl G, Dierich A, LeMeur M, Guillemot F (2000) Neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc Natl Acad Sci USA 97:1607–1611PubMedCrossRef

15.

Naya FJ, Stellrecht CM, Tsai MJ (1995) Tissue-specific regulation of the insulin gene by a novel basic helix-loop-helix transcription factor. Genes Dev 9:1009–1019PubMedCrossRef

16.

Habener JF, Kemp DM, Thomas MK (2005) Minireview: transcriptional regulation in pancreatic development. Endocrinology 146:1025–1034PubMedCrossRef

17.

Gu G, Wells JM, Dombkowski D, Preffer F, Aronow B, Melton DA (2004) Global expression analysis of gene regulatory pathways during endocrine pancreatic development. Development 131:165–179PubMedCrossRef

18.

Wang R, Bouwens L, Kloppel G (1994) Beta cell proliferation in normal and streptozotocin-treated newborn rats: site, dynamics and capacity. Diabetologia 37:1088–1096PubMedCrossRef

19.

Yashpal NK, Li J, Wang R (2004) Characterization of c-Kit and nestin expression during islet cell development in the prenatal and postnatal rat pancreas. Dev Dyn 229:813–825PubMedCrossRef

20.

Wang R, Li J, Yashpal NK (2004) Phenotypic analysis of c-Kit expression in epithelial monolayers derived from postnatal rat pancreatic islets. J Endocrinol 182:113–122PubMedCrossRef

21.

Brands K, Colvin E, Williams LJ, Wang R, Lock RB, Tuch BE (2008) Reduced immunogenicity of first trimester human fetal pancreas. Diabetes 57:627–634PubMedCrossRef

22.

Wang R, Li J, Lyte K, Yashpal NK, Fellows F, Goodyer CG (2005) Role for β1-integrin and its associated α3, α5 and α6 subunits in development of the human fetal pancreas. Diabetes 54:2080–2089PubMedCrossRef

23.

Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2^-DDCT Method. Methods 25:402–408PubMedCrossRef

24.

Dallas PB, Gottardo NG, Firth MJ et al (2005) Gene expression levels assessed by oligonucleotide microarray analysis and quantitative real-time RT-PCR—how well do they correlate? BMC Genomics 6:59–69PubMedCrossRef

25.

Ackermann AM, Gannon M (2007) Molecular regulation of pancreatic β-cell mass development, maintenance, and expansion. J Mol Endocrinol 38:193–206PubMedCrossRef

26.

Johannasen K, Dursun U, Jordan N et al (2007) Temporal control of neurogenin3 activity in pancreas progenitors reveals competence windows for the generation of different endocrine cell types. Development 12:457–465

27.

Wang J, Cortina G, Wu SV et al (2006) Mutant neurogenin-3 in congenital malabsorptive diarrhea. N Engl J Med 355:270–280PubMedCrossRef

28.

Doyle MJ, Loomis ZL, Sussel L (2007) Nkx2.2-repressor activity is sufficient to specify alpha cells and a small number of beta cells in the pancreatic islet. Development 134:515–523PubMedCrossRef

29.

Doyle MJ, Sussel L (2007) Nkx2.2 regulates beta cell function in the mature islet. Diabetes 56:1999–2007PubMedCrossRef

30.

Jørgensen MC, Ahnfelt-Rønne J, Hald J, Madsen OD, Serup P, Hecksher-Sørensen J (2007) An illustrated review of early pancreas development in the mouse. Endocr Rev 28:685–705PubMedCrossRef

31.

Schisler JC, Jensen PB, Taylor DG et al (2005) The Nkx6.1 homeodomain transcription factor suppresses glucagon expression and regulates glucose-stimulated insulin secretion in islet beta cells. Proc Natl Acad Sci USA 102:7297–7302PubMedCrossRef

32.

Henseleit KD, Nelson SB, Kuhlbordt K, Hennings JC, Ericson J, Sander M (2005) Nkx6 transcription factor activity is required for α- and β-cell development in the pancreas. Development 132:3139–3149PubMedCrossRef

Titel: Transcription factor expression in the developing human fetal endocrine pancreas
verfasst von: B. M. Lyttle
J. Li
M. Krishnamurthy
F. Fellows
M. B. Wheeler
C. G. Goodyer
R. Wang
Publikationsdatum: 01.07.2008
Verlag: Springer-Verlag
Erschienen in: Diabetologia / Ausgabe 7/2008
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-008-1006-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Transcription factor expression in the developing human fetal endocrine pancreas

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Costims – das nächste heiße Ding in der Krebstherapie?

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2008

Glibenclamide activates translation in rat pancreatic beta cells through calcium-dependent mTOR, PKA and MEK signalling pathways

Abnormal lipid profile and hyperinsulinaemia after a mixed meal: additional cardiovascular risk factors in young adults born preterm

Age influences DNA methylation and gene expression of COX7A1 in human skeletal muscle

Blood vessels of human islets of Langerhans are surrounded by a double basement membrane

The glucose-lowering agent sodium tungstate increases the levels and translocation of GLUT4 in L6 myotubes through a mechanism associated with ERK1/2 and MEF2D

Generalised reduction of putative endothelial progenitors and CXCR4-positive peripheral blood cells in type 2 diabetes

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Costims – das nächste heiße Ding in der Krebstherapie?

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

Update Innere Medizin